Success Stories: With the Help of NAILG, a Pharmaceutical Chemist from India Received His I-140 NIW Along with His EB-1A
Client’s Testimonial:
“While thanking you for all the fruitful efforts from your team, Many thanks for your support in this regard.”
On August 2nd, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Chemist in the field of Pharmaceutical Sciences (Approval Notice).
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Pharmaceutical Chemist
Country of Origin: India
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: August 2nd, 2021
Processing Time: 16 months, 25 days
Case Summary:
“The United States significantly benefits from [the client’s] studies in this area, as his findings enable the creation of advanced pharmaceuticals that treat thousands of diseases in the country. These public health and economic benefits make the promotion of this industry a national priority. By enhancing the capacity of drug delivery systems, [the client] is supporting the advancement of the pharmaceutical industry and facilitating a nationally valuable sector.”
“Among the many researchers working in this area, one who stands out is [the client]. His findings advance the application of anti-cancer drugs and support the public health of the United States.”
These excerpts are from some of the recommendation letters that our client, a pharmaceutical chemist from India, procured to be used for his petition to USCIS. We at North America Immigration Law Group made sure that all of the documents and relevant information were in place before moving ahead with his NIW (National Interest Waiver) application. Having helped over 25,000 clients in their adjudication process, we were certain that we could lead this case to victory. To assure this outcome, we included the following along with aforesaid letters of support.
- His research has resulted in 37 peer-reviewed journal articles (ten of them first-authored). Moreover, these papers have been published in the top journals in his field, reflecting his peers’ recognition of the value of this research. He has published papers in no fewer than four highly ranked peer-reviewed journals.
- Due to his knowledge and expertise in the field, our client has been regularly invited to conduct peer reviews for elite journals in the field. Our client has completed at least 5 peer reviews to date.
- His publications have been cited a total of 110 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of pharmaceutical sciences. He has thus authored one paper that ranks among the top 1.00% most-cited articles across the entire field for Pharmacology & Toxicology for its respective year of publication. Upon reviewing his citation record, it is clear that he has had a major influence on other scholars’ understanding of topics such as compound synthesis and drug delivery.